Capital-E

Accelleran, founded in 2013 and headquartered in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company focuses on providing an economically viable alternative to traditional mobile telecom solutions through its open and containerized radio access network (RAN) software. Accelleran’s offerings leverage cloud-native techniques that enhance flexibility, innovation, and scalability while maintaining hardware independence. By facilitating the deployment of multi-vendor, disaggregated Private 5G networks akin to WiFi, Accelleran empowers businesses to achieve real-time network control, automation, and an enhanced user experience. Through collaboration with a diverse ecosystem of partners, the company is positioned to support both private and public network needs effectively.

Accelleran, founded in 2013 and headquartered in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company focuses on providing an economically viable alternative to traditional mobile telecom solutions through its open and containerized radio access network (RAN) software. Accelleran’s offerings leverage cloud-native techniques that enhance flexibility, innovation, and scalability while maintaining hardware independence. By facilitating the deployment of multi-vendor, disaggregated Private 5G networks akin to WiFi, Accelleran empowers businesses to achieve real-time network control, automation, and an enhanced user experience. Through collaboration with a diverse ecosystem of partners, the company is positioned to support both private and public network needs effectively.

Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.

PharmaDiagnostics NV is a Belgian company specializing in the development of analytical techniques aimed at enhancing the drug discovery process. Based in Zellik, the company offers a range of assays tailored for the pharmaceutical and biotech sectors, including human albumin binding, human orosomucoid, membrane, and redox potential assays. Additionally, PharmaDiagnostics provides assay systems that encompass experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and the solubility of new chemical entities under both fasted and fed intestinal conditions. Through its innovative solutions, PharmaDiagnostics plays a crucial role in supporting drug development efforts.

PharmaDiagnostics NV is a Belgian company specializing in the development of analytical techniques aimed at enhancing the drug discovery process. Based in Zellik, the company offers a range of assays tailored for the pharmaceutical and biotech sectors, including human albumin binding, human orosomucoid, membrane, and redox potential assays. Additionally, PharmaDiagnostics provides assay systems that encompass experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and the solubility of new chemical entities under both fasted and fed intestinal conditions. Through its innovative solutions, PharmaDiagnostics plays a crucial role in supporting drug development efforts.

Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.